Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of VYNE will rise by +3.97% over the next 2 Weeks and hit $0.66 by Thursday, May 14, 2026. In that time frame, VYNE's share price is expected to range between $0.65 and $0.68.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 14, 2026 | 0.65 | 0.66 | 0.68 |
| May 13, 2026 | 0.65 | 0.66 | 0.67 |
| May 12, 2026 | 0.64 | 0.66 | 0.67 |
| May 11, 2026 | 0.64 | 0.66 | 0.67 |
| May 8, 2026 | 0.63 | 0.65 | 0.66 |
| May 7, 2026 | 0.64 | 0.65 | 0.66 |
| May 6, 2026 | 0.64 | 0.65 | 0.66 |
| May 5, 2026 | 0.63 | 0.64 | 0.66 |
| May 4, 2026 | 0.63 | 0.64 | 0.65 |
| May 1, 2026 | 0.62 | 0.63 | 0.65 |
VYNE shares rose +0.71% in Friday, May 1, 2026's trading session, rising from a previous close of $0.64 to move at $0.64. The stock demonstrated notable intraday movement (see VYNE's key stats for a full breakdown), fluctuating between $0.64 and $0.64, a +1.05% trading range. While recent weeks have seen some volatility, VYNE has managed to secure a +3.82% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 37.56K shares changing hands, 9.23K more than the previous session. This amounted to $24.08K in total market activity.
Will VYNE Continue Its Upward Trend?
According to analyst ratings and projections for VYNE, VYNE Therapeutics Inc. shares are anticipated to increase by +5.05%, potentially reaching $0.68 per share by May 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for VYNE. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the VYNE stock forecast, now is a good time to buy VYNE stock because its current trading price is -3.14% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on VYNE covering social and institutional perspectives.
VYNE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into VYNE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 58.71% to 60.97%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 54.65%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 48.30%, maintains a neutral outlook for the long term. Insights into VYNE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
VYNE Therapeutics Short-Term Forecasts
VYNE Forecast For Next 5 Days
Our algorithm anticipates VYNE Therapeutics (VYNE) stock could hit $0.63 by May 08, 2026. This represents a -1.26% rise from today's price, following a +2.48% change over the past five days.
VYNE Forecast For Next 30 Days
Based on analysis of market trends, the outlook for VYNE Therapeutics Inc. (VYNE) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.65, which would mean a +1.37% increase from the current price of $0.64. Projections for this period range from a high of $0.68 to a low of $0.62.
VYNE Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for VYNE Therapeutics's price over the next three months point to a rise. VYNE stock is expected to peak at $2.51 on May 11, 2026 before potentially dipping to $1.06 on Jul 23, 2026. On average, VYNE is likely to trade around $1.82 in the coming 90 days.
VYNE Therapeutics Stock Forecast 2025
Based on our predictive models, VYNE Therapeutics (VYNE) is expected to trade between $0.02 and $2.53 throughout 2026. This would result in an average price of $1.74, potentially offering investors a +171.37% return from current levels.
VYNE Therapeutics Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, VYNE Therapeutics Inc. (VYNE) is positioned to show a strong performance in May 2026. The price is predicted to move between $1.96 and $2.51, settling at an average of $2.29. This could translate to a +257.14% gain.
June 2026
Based on current market signals, VYNE Therapeutics Inc. is projected to trend june 2026. We forecast a trading range from $1.55 to $2.16, with a likely average price of $1.83. Investors could expect a potential return of +185.40%.
July 2026
Our predictive algorithms indicate VYNE Therapeutics Inc. stock may see a shift in July 2026. The expected range spans $1.06–$1.80, with an average target of $1.39. This represents a positive outlook and a possible gain of +116.78%.
August 2026
Analyzing established trends, VYNE Therapeutics Inc. looks set to move in August 2026. Projections place the stock between $1.32 and $2.53, averaging around $2.10. This suggests a +227.51% gain from current levels.
September 2026
Market indicators suggest VYNE Therapeutics Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.95 to $2.38, with a midpoint forecast of $1.93. The stock might deliver a +201.00% gain.
October 2026
Forecasting for October 2026, models estimate that VYNE Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.51 and $1.40, averaging $1.14. This signals a positive trajectory with potential returns around +77.79%.
November 2026
According to our latest forecast models, VYNE Therapeutics Inc. (VYNE) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.57 and $2.03, settling at an average of $1.99. This could translate to a +210.36% gain.
December 2026
Based on current market signals, VYNE Therapeutics Inc. is projected to trend december 2026. We forecast a trading range from $0.02 to $1.67, with a likely average price of $1.32. Investors could expect a potential return of +105.86%.
January 2027
Our predictive algorithms indicate VYNE Therapeutics Inc. stock may see a shift in January 2027. The expected range spans $0.00–$1.51, with an average target of $1.74. This represents a positive outlook and a possible gain of +171.37%.
February 2027
Analyzing established trends, VYNE Therapeutics Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $1.43, averaging around $1.93. This suggests a +201.00% gain from current levels.
March 2027
Market indicators suggest VYNE Therapeutics Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $1.12, with a midpoint forecast of $1.52. The stock might deliver a +137.06% gain.
April 2027
Forecasting for April 2027, models estimate that VYNE Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.65, averaging $2.33. This signals a positive trajectory with potential returns around +263.38%.
VYNE's history of dividends and stock splits also plays a role in long-term investor confidence.

